Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Salmi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|February 21, 1994
Antagonism by SCH 23390 of clozapine-induced hypothermia in the ratP Salmi, T Karlsson, S Ahlenius
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 19, 1999
In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptorsS Ahlenius, I Henriksson, O Magnusson, et al.
Pharmacology & Toxicology|June 1, 1993
Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesisS Ahlenius, V Hillegaart, P Salmi, et al.
Acta Physiologica Scandinavica|September 27, 2003
Lack of efficacy of 'naked' small interfering RNA applied directly to rat brainR Isacson, B Kull, P Salmi, et al.
Neuroscience|February 13, 2004
A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?R Isacson, B Kull, C Wahlestedt, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1996
[Insulin dependent diabetes mellitus patients benefit from teaching programs]L Mäkelä, P Nikkanen, P Salmi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1998
Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated ratsP Salmi, K Malmgren, T H Svensson, et al.
Behavioural Brain Research|June 7, 2000
Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotionP A Jiménez Vasquez, P Salmi, S Ahlenius, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1996
Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the ratM L Wadenberg, P Salmi, P Jimenez, et al.
International Endodontic Journal|March 1, 1997
Microbiological findings and clinical treatment procedures in endodontic cases selected for microbiological investigationE K Siren, M P Haapasalo, K Ranta, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|February 21, 1994
Antagonism by SCH 23390 of clozapine-induced hypothermia in the ratP Salmi, T Karlsson, S Ahlenius
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 19, 1999
In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptorsS Ahlenius, I Henriksson, O Magnusson, et al.
Pharmacology & Toxicology|June 1, 1993
Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesisS Ahlenius, V Hillegaart, P Salmi, et al.
Acta Physiologica Scandinavica|September 27, 2003
Lack of efficacy of 'naked' small interfering RNA applied directly to rat brainR Isacson, B Kull, P Salmi, et al.
Neuroscience|February 13, 2004
A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?R Isacson, B Kull, C Wahlestedt, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1996
[Insulin dependent diabetes mellitus patients benefit from teaching programs]L Mäkelä, P Nikkanen, P Salmi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1998
Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated ratsP Salmi, K Malmgren, T H Svensson, et al.
Behavioural Brain Research|June 7, 2000
Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotionP A Jiménez Vasquez, P Salmi, S Ahlenius, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1996
Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the ratM L Wadenberg, P Salmi, P Jimenez, et al.
International Endodontic Journal|March 1, 1997
Microbiological findings and clinical treatment procedures in endodontic cases selected for microbiological investigationE K Siren, M P Haapasalo, K Ranta, et al.
Pageof 3